Chronic Myeloid Leukemia

Learning Objectives

  • Describe history of CML
  • Describe current available treatment for CML
  • Understand choice of frontline thereapy for chronic-phase CML
  • Monitor response to frontline TKI therapy
  • Understand treatment-related toxicity

Course summary

Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
Registration Opens: 
01/16/2020
Registration Expires: 
01/15/2022
Part of: 
Advanced Practice Provider Webinar Lecture Series 2020
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
Please login or register to take this course.